Literature DB >> 26396139

Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury.

Yue Zhou1, Qiying Chen2, Kar Sheng Lew1, A Mark Richards3, Peipei Wang4.   

Abstract

BACKGROUND: A highly efficient approach to select microRNA (miRNA) targets is a key to develop a miRNA-based therapeutic approach to cardiac ischemia-reperfusion (I/R). To reverse the change induced by disease, I/R in this case, is the traditional strategy to develop therapeutic drugs. However, examples show that it will not always serve the purpose. In this study, we demonstrate an additional approach of selecting miRNA targets with therapeutic potential following cues from cardioprotection-induced changes rather than by reversing disease-induced changes in cardiac I/R.
METHODS: Isolated perfused rat hearts subjected to I/R were treated with 50 μmol/L sodium hydrosulfide (NaHS) or 10 nmol/L urocortin 2 (UCN2). Cardiac miRNA regulations were determined by miRNA array. Functional screening of selected miRNA mimics, assessed by WST (2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) activity and lactate dehydrogenase (LDH) release, was performed in H9c2 and neonatal rat ventricular myocytes (NRVMs) with hypoxia/reoxygenation. RNA-induced silencing complex (RISC)-loaded miRNAs caused by mimic transfection were quantified following argonaute-2 immunoprecipitation. Gene regulations of 1 selected miRNA were determined by quantitative polymerase chain reaction and Western blot.
RESULTS: Treatment with NaHS and UCN2 significantly improved cardiac function and reduced LDH release. The miRNA array indicated a panel of commonly up- and downregulated miRNAs. Among them, 10 upregulated miRNAs with antiapoptotic and antiautophagy potentials were selected for further screening. Mimics of miRNA-221, -150, and -206 were protective in both H9c2 and NRVM. RISC-loaded miRNAs were up by ∼20-fold above. To further prove the feasibility of this approach, miRNA-221 was studied. It reduced I/R-induced caspase 3/7 activity and LC3-II (microtubule-associated protein 1 light chain 3). Measuring genes predicted to regulate apoptosis and autophagy, miRNA-221 mimic decreased Ddit4, TP53inp1, and p27 at both messenger RNA (mRNA) and protein levels, and reduced mRNA of Bak1 and Puma and proteins of Bim and Bmf.
CONCLUSION: Mimicking miRNA changes caused by cardioprotective agents, combined with functional screening, enables investigators to efficiently identify novel miRNAs with therapeutic potential in cardiac I/R.
© The Author(s) 2015.

Entities:  

Keywords:  apoptosis; autophagy; cardioprotection; ischemia/reperfusion (I/R); microRNA (miRNA); therapeutic target

Mesh:

Substances:

Year:  2015        PMID: 26396139     DOI: 10.1177/1074248415604463

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  21 in total

1.  Ratio-Based Method To Identify True Biomarkers by Normalizing Circulating ncRNA Sequencing and Quantitative PCR Data.

Authors:  Youping Deng; Yong Zhu; Hongwei Wang; Vedbar S Khadka; Ling Hu; Junmei Ai; Yuhong Dou; Yan Li; Shengming Dai; Christopher E Mason; Yunliang Wang; Wei Jia; Jicai Zhang; Gang Huang; Bin Jiang
Journal:  Anal Chem       Date:  2019-04-30       Impact factor: 6.986

2.  Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 3.  Non-coding RNAs modulate autophagy in myocardial ischemia-reperfusion injury: a systematic review.

Authors:  Fuwen Huang; Jingting Mai; Jingwei Chen; Yinying He; Xiaojun Chen
Journal:  J Cardiothorac Surg       Date:  2021-05-22       Impact factor: 1.637

4.  miR-194-5p protects against myocardial ischemia/reperfusion injury via MAPK1/PTEN/AKT pathway.

Authors:  Qiufeng Zhang; Xiaotian Wu; Jie Yang
Journal:  Ann Transl Med       Date:  2021-04

5.  MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities.

Authors:  Yaoran Tu; Yong Hu
Journal:  Metab Brain Dis       Date:  2021-04-12       Impact factor: 3.655

6.  Urocortin Treatment Improves Acute Hemodynamic Instability and Reduces Myocardial Damage in Post-Cardiac Arrest Myocardial Dysfunction.

Authors:  Chien-Hua Huang; Chih-Hung Wang; Min-Shan Tsai; Nai-Tan Hsu; Chih-Yen Chiang; Tzung-Dau Wang; Wei-Tien Chang; Huei-Wen Chen; Wen-Jone Chen
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

7.  Comparative mRNA and MicroRNA Profiling during Acute Myocardial Infarction Induced by Coronary Occlusion and Ablation Radio-Frequency Currents.

Authors:  Eduardo T Santana; Regiane Dos Santos Feliciano; Andrey J Serra; Eduardo Brigidio; Ednei L Antonio; Paulo J F Tucci; Lubov Nathanson; Mariana Morris; José A Silva
Journal:  Front Physiol       Date:  2016-11-25       Impact factor: 4.566

8.  miR-125a, miR-139 and miR-324 contribute to Urocortin protection against myocardial ischemia-reperfusion injury.

Authors:  Ignacio Díaz; Eva Calderón-Sánchez; Raquel Del Toro; Javier Ávila-Médina; Eva Sánchez de Rojas-de Pedro; Alejandro Domínguez-Rodríguez; Juan Antonio Rosado; Abdelkrim Hmadcha; Antonio Ordóñez; Tarik Smani
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

9.  Identification of novel microRNAs in the sheep heart and their regulation in heart failure.

Authors:  Lee Lee Wong; Miriam T Rademaker; Eng Leng Saw; Kar Sheng Lew; Leigh J Ellmers; Christopher J Charles; Arthur Mark Richards; Peipei Wang
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

10.  Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect cardiomyocytes from simulated ischemia-reperfusion injury.

Authors:  Kyoung-Mi Park; Jian-Peng Teoh; Yongchao Wang; Zuzana Broskova; Ahmed S Bayoumi; Yaoliang Tang; Huabo Su; Neal L Weintraub; Il-Man Kim
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-06-10       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.